Abstract:Background Long‐term use of antiplatelet agents after acute coronary syndrome in diabetic patients is not well known. Here, we describe antiplatelet use and outcomes in such patients enrolled in the EPICOR Asia (Long‐Term Follow‐up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Asia) registry. Methods and Results EPICOR Asia is a prospective, observational study of 12 922 patients with acute coronary syndrome surviving to discharge, from 8 countries/regions in Asia. The present analysis included 3162 patients with diabetes mellitus (DM) and 9602 patients without DM. The impact of DM on use of antiplatelet agents and events (composite of death, myocardial infarction, and stroke, with or without any revascularization; individual components, and bleeding) was evaluated. Significant baseline differences were seen between patients with DM and patients without DM for age, sex, body mass index, cardiovascular history, angiographic findings, and use of percutaneous coronary intervention. At discharge, ≈90% of patients in each group received dual antiplatelet therapy. At 2‐year follow‐up, more patients with DM tended to still receive dual antiplatelet therapy (60% versus 56%). DM was associated with increased risk from ischemic but not major bleeding events. Independent predictors of the composite end point of death, myocardial infarction, and stroke in patients with DM were age ≥65 years and use of diuretics at discharge. Conclusions Antiplatelet agent use is broadly comparable in patients with DM and patients without DM, although patients with DM are more likely to be on dual antiplatelet therapy at 2 years. Patients with DM are at increased risk of ischemic events, suggesting an unmet need for improved antithrombotic treatment. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01361386. Nonstandard Abbreviations and Acronyms DAPT dual antiplatelet therapy DM diabetes mellitus EPICOR Long‐Term Follow‐up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients PoCE patient‐oriented composite end point Clinical Perspective What Is New? Among patients surviving an acute coronary syndrome, ≈90% of both patients with diabetes mellitus (DM) and patients without DM were discharged on dual antiplatelet therapy, but somewhat more patients with DM than patients without DM were on dual antiplatelet therapy at 2 years after discharge (60% versus 56%). Although DM was associated with increased risk of ischemic events during follow‐up, there was minimal impact on risk of major bleeding. Multivariable analysis showed that independent predictors of the composite end point of death, myocardial infarction, and stroke in patients with DM were older age (≥65 years) and use of diuretics at discharge. What Are the Clinical Implications? Despite a higher rate of dual antiplatelet therapy use in patients with DM than patients without DM at 2 years after an acute coronary syndrome, patients with DM were at increased risk of ischemic but not bleeding events, suggesting an unmet need for improved antithrombotic treatment. According to the International Diabetes Federation, in 2015, there were ≈415 million patients worldwide aged 20 to 79 with diabetes mellitus (DM), along with a further 193 million undiagnosed cases. 1 Type 2 DM accounts for up to 90% of all cases, and the prevalence is increasing globally. 1 About half of all deaths in patients with DM are due to cardiovascular disease, 1 the majority resulting from thrombotic events. 2 In addition, patients with DM have a 2‐ to 4‐fold higher risk of recurrent atherothrombotic events and vascular complications than those without DM. 2 Along with oxidative stress, inflam -Abstract Truncated-

Conditional-Based Refactorings and Fault-Proneness: An Empirical Study

Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting

THE CORONARY ANGIOGRAPHY FEATURES AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CORONARY HEART DISEASE COMPLICATED TYPE 2 DIABETES MELLITUS

Impact of diabetes mellitus status on coronary pathoanatomy and interventional treatment: insights from the Euro heart survey PCI registry

Analysis of Angiographic Patterns in Acute Coronary Syndrome Patients With Diabetes Mellitus: Correlation With HbA1c Levels

Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome

Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects

Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint

Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials

Diabetes: preventing coronary heart disease in a high risk group

[Fibro-bronchoscopy during resuscitation of patients suffering from severe thoracic traumatisms (author's transl)].

The electric field assisted drug release from polyacrylamide hydrogels

Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis

Correlation of Hba1c Levels With Clinical Outcomes in Patients with Acute Coronary Syndrome

Diabetes and multivessel disease: coronary artery bypass grafting remains king

HbA1c is a predictive factor of severe coronary stenosis and major adverse cardiovascular events in patients with both type 2 diabetes and coronary heart disease

Abstract 11341: Diabetes and Chronic Kidney Disease: Prevalence, Associated Factors and Influence on Optimal Medical Therapy in Patients with Coronary Artery Disease

Ylidene-->iminophosphine coordination complexes and reversible dissociation of dichlorophosphetidines.

Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study.

Prognostic value of quantitative anatomical and functional measures of coronary artery disease in diabetic and non-diabetic patients